Razobazam

In this article we are going to explore the topic of Razobazam in depth, analyzing its different aspects and its possible implications. Razobazam is a topic that has been debated for a long time, and is relevant in various contexts, from the personal to the professional sphere. Throughout this article, we will examine the various perspectives that exist on Razobazam, as well as its evolution over time. Likewise, we will try to shed light on the possible future implications of Razobazam and its impact on our society. We hope that this article can provide a broad and comprehensive overview of Razobazam, helping readers better understand this topic and its implications.

Razobazam
Identifiers
  • 3,8-dimethyl-4-phenyl-2H-pyrazolodiazepine-5,7-dione
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC14H14N4O2
Molar mass270.292 g·mol−1
3D model (JSmol)
  • CC1=C2C(=NN1)N(C(=O)CC(=O)N2C3=CC=CC=C3)C
  • InChI=1S/C14H14N4O2/c1-9-13-14(16-15-9)17(2)11(19)8-12(20)18(13)10-6-4-3-5-7-10/h3-7H,8H2,1-2H3,(H,15,16)
  • Key:RHZDHINXKVZTEF-UHFFFAOYSA-N
  (verify)

Razobazam (INN) is a drug which is a benzodiazepine derivative. Its mechanism of action appears to be quite different from that of most benzodiazepine drugs, and it produces nootropic effects in animal studies.

See also

References

  1. ^ Hock FJ, Scheich H (November 1986). "Functional activity in the brain of socially deprivated rats produced by an active avoidance test after razobazam (Hoe 175) treatment: a 2-deoxyglucose study". Behavioral and Neural Biology. 46 (3): 398–409. doi:10.1016/s0163-1047(86)90401-2. PMID 3814045.